Roy D. Baynes - Jun 8, 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ David Tucker, Attorney-in-Fact
Stock symbol
ATRA
Transactions as of
Jun 8, 2021
Transactions value $
$0
Form type
4
Date filed
6/9/2021, 07:03 PM
Previous filing
Jun 2, 2021
Next filing
May 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Award $0 +11K +91.67% $0.00 23K Jun 8, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRA Non-Qualified Stock Option (Right to Buy) Award $0 +17.5K $0.00 17.5K Jun 8, 2021 Common Stock 17.5K $13.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units shall vest on the earlier of June 8, 2022 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
F2 The option shall vest on the earlier of June 8, 2022 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.